133 related articles for article (PubMed ID: 10947340)
1. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.
Anell A; Svarvar P
Pharmacoeconomics; 2000 Feb; 17(2):175-85. PubMed ID: 10947340
[TBL] [Abstract][Full Text] [Related]
2. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomics and formulary decision making.
Sanchez LA
Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
[TBL] [Abstract][Full Text] [Related]
4. Application of pharmacoeconomics to formulary decision making in managed care organizations.
Suh DC; Okpara IR; Agnese WB; Toscani M
Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
Mullins CD; Wang J
Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
[TBL] [Abstract][Full Text] [Related]
6. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.
Alsultan MS
Saudi Pharm J; 2011 Jan; 19(1):51-6. PubMed ID: 23960742
[TBL] [Abstract][Full Text] [Related]
7. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
[TBL] [Abstract][Full Text] [Related]
8. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
Lipsy RJ
Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
[TBL] [Abstract][Full Text] [Related]
9. Barriers to implementing pharmacoeconomics: interview study.
Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
[No Abstract] [Full Text] [Related]
10. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Weekes LM; Day RO
Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
[TBL] [Abstract][Full Text] [Related]
11. Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee's list of recommended essential medicines (the 'Wise List').
Eriksen J; Ovesjö ML; Vallin M; Juhasz-Haverinen M; Andersén-Karlsson E; Ateva K; Gustafsson LL; Jirlow M; Bastholm-Rahmner P
Eur J Clin Pharmacol; 2018 Jan; 74(1):131-138. PubMed ID: 29063149
[TBL] [Abstract][Full Text] [Related]
12. A pharmacoeconomics and formulary management collaborative project to teach decision analysis principles.
Cavanaugh TM; Buring S; Cluxton R
Am J Pharm Educ; 2012 Aug; 76(6):115. PubMed ID: 22919091
[TBL] [Abstract][Full Text] [Related]
13. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence prescribing decisions.
Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
[TBL] [Abstract][Full Text] [Related]
15. Multi-tier drugs assessment in a decentralised health care system. The Italian case-study.
Jommi C; Costa E; Michelon A; Pisacane M; Scroccaro G
Health Policy; 2013 Oct; 112(3):241-7. PubMed ID: 23850166
[TBL] [Abstract][Full Text] [Related]
16. The use of pharmacoeconomic data in formulary selection.
Hatoum HT; Freeman RA
Top Hosp Pharm Manage; 1994 Jan; 13(4):47-53. PubMed ID: 10130683
[TBL] [Abstract][Full Text] [Related]
17. Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.
Burke N; Bowen JM; Troyan S; Jegathisawaran J; Gosse C; Tonkin M; Kagoma S; Goeree R; Holbrook A
Can J Hosp Pharm; 2016; 69(3):187-93. PubMed ID: 27402997
[TBL] [Abstract][Full Text] [Related]
18. The role of pharmacoeconomic guidelines for formulary approval: the Australian experience.
Langley PC
Clin Ther; 1993; 15(6):1154-76; discussion 1120. PubMed ID: 8111812
[TBL] [Abstract][Full Text] [Related]
19. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
20. [The responsibility for medications list should be clear. Swedish Drug Committees (LOK) has published guidelines].
Rahmner PB; Lundborg M
Lakartidningen; 2011 Jun 1-14; 108(22-23):1250-2. PubMed ID: 21786501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
